Literature DB >> 11694324

Leukotrienes play protective roles early during experimental VSV encephalitis.

N Chen1, A Restivo, C S Reiss.   

Abstract

Leukotrienes (LT) are potent lipid mediators of inflammation. 5-Lipoxygenase (5-LO) is the key enzyme in the conversion of arachidonic acid to LT. There are four LT: LTB(4), LTC(4), LTD(4) and LTE(4). LT have been extensively studied in airway inflammation but little is known about their roles in viral infection in the CNS. LTB(4) is a chemoattractant for neutrophils. In this work, we studied the roles of LT in acute vesicular stomatitis virus (VSV) encephalitis. Two methods were used to disrupt 5-LO activity: mice were treated with Zileuton, an enzyme antagonist, or 5-LO genetic knockout mice were used. We found that inhibition or deletion of 5-LO resulted in: (a) impaired process of neutrophil infiltration into the CNS early during viral infection; (b) fewer neurons expressed nitric oxide synthase-1 (NOS-1); (c) higher viral titers 1 day after viral infection; and (d) increased disruption of blood brain barrier (BBB). Our studies suggest that LT are important innate immune players during VSV pathogenesis and are beneficial to the host in early control of viral replication in the CNS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11694324     DOI: 10.1016/s0165-5728(01)00415-5

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  17 in total

1.  rVSV(M Delta 51)-M3 is an effective and safe oncolytic virus for cancer therapy.

Authors:  Lan Wu; Tian-gui Huang; Marcia Meseck; Jennifer Altomonte; Oliver Ebert; Katsunori Shinozaki; Adolfo García-Sastre; John Fallon; John Mandeli; Savio L C Woo
Journal:  Hum Gene Ther       Date:  2008-06       Impact factor: 5.695

2.  Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase.

Authors:  Carlos H C Serezani; David M Aronoff; Sonia Jancar; Peter Mancuso; Marc Peters-Golden
Journal:  Blood       Date:  2005-02-17       Impact factor: 22.113

3.  Sleep and behavior during vesicular stomatitis virus induced encephalitis in BALB/cJ and C57BL/6J mice.

Authors:  Mayumi Machida; Marta A Ambrozewicz; Kimberly Breving; Laurie L Wellman; Linghui Yang; Richard P Ciavarra; Larry D Sanford
Journal:  Brain Behav Immun       Date:  2013-09-18       Impact factor: 7.217

Review 4.  Understanding and altering cell tropism of vesicular stomatitis virus.

Authors:  Eric Hastie; Marcela Cataldi; Ian Marriott; Valery Z Grdzelishvili
Journal:  Virus Res       Date:  2013-06-22       Impact factor: 3.303

5.  Gene expression contributing to recruitment of circulating cells in response to vesicular stomatitis virus infection of the CNS.

Authors:  Derek D C Ireland; Carol Shoshkes Reiss
Journal:  Viral Immunol       Date:  2006       Impact factor: 2.257

6.  Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis.

Authors:  Alexandra I Medeiros; Anderson Sá-Nunes; Edson G Soares; Camila M Peres; Célio L Silva; Lúcia H Faccioli
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

7.  Role of peripheral immune response in microglia activation and regulation of brain chemokine and proinflammatory cytokine responses induced during VSV encephalitis.

Authors:  Christina D Steel; Kimberly Breving; Susan Tavakoli; Woong-Ki Kim; Larry D Sanford; Richard P Ciavarra
Journal:  J Neuroimmunol       Date:  2013-12-11       Impact factor: 3.478

8.  Neuropeptides activate human mast cell degranulation and chemokine production.

Authors:  Marianna Kulka; Cecilia H Sheen; Brian P Tancowny; Leslie C Grammer; Robert P Schleimer
Journal:  Immunology       Date:  2007-10-06       Impact factor: 7.397

9.  Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenocarcinoma.

Authors:  Eric Hastie; Dahlia M Besmer; Nirav R Shah; Andrea M Murphy; Megan Moerdyk-Schauwecker; Carlos Molestina; Lopamudra Das Roy; Jennifer M Curry; Pinku Mukherjee; Valery Z Grdzelishvili
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

10.  Nuclear localization of 5-lipoxygenase as a determinant of leukotriene B4 synthetic capacity.

Authors:  Ming Luo; Sandra M Jones; Marc Peters-Golden; Thomas G Brock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.